Gabapentin
GABARONE, Gaba 300-EZS, Gralise, Neurontin, RELGAABI
Anticonvulsant / Neuropathic Pain Agent
NADAC/unit
$0.0211
No Shortage
Tier 1: 220.1%
PA Req: 41.3%
28 Manufacturers
102 ANDAs
Gabapentin Capsules, USP are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, ....
vs. brand GABARONE: Generic saves up to 100% per unit
Market Intelligence
2025-10-29 Class II Recall: The Harvard Drug Group LLC
2025-10-29 Class II Recall: The Harvard Drug Group LLC
2025-07-09 Class II Recall: The Harvard Drug Group LLC
2025-07-09 Class II Recall: The Harvard Drug Group LLC
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ABON PHARMACEUTICALS LLCACELLA PHARMACEUTICALS LLCACTAVIS ELIZABETH LLCAJENAT PHARMACEUTICALS LLCALKEM LABORATORIES LTDALMATICA PHARMA INCAMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS NY LLCANNORA PHARMA PRIVATE LTDASCENT PHARMACEUTICALS INCAUROBINDO PHARMA LTDCSPC OUYI PHARMACEUTICAL CO LTDGLENMARK PHARMACEUTICALS LTDGRANULES INDIA LTDHUMANWELL PHARMACEUTICAL US INCINVAGEN PHARMACEUTICALS INCIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USALAURUS LABS LTDMARKSANS PHARMA LTDMISSION PHARMACAL COPAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INCPRINSTON PHARMACEUTICAL INCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSCIEGEN PHARMACEUTICALS INCSENORES PHARMACEUTICALS INCSTRIDES PHARMA GLOBAL PTE LTDVIATRIS SPECIALTY LLCZHEJIANG YONGTAI PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.